Annual CFI
-$27.80 M
+$110.60 M+79.91%
December 1, 2024
Summary
- As of March 12, 2025, TRDA annual cash flow from investing activities is -$27.80 million, with the most recent change of +$110.60 million (+79.91%) on December 1, 2024.
- During the last 3 years, TRDA annual CFI has fallen by -$23.22 million (-506.94%).
- TRDA annual CFI is now -4312.38% below its all-time high of -$630.00 thousand, reached on December 31, 2019.
Performance
TRDA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$53.37 M
+$136.29 M+164.35%
December 1, 2024
Summary
- As of March 12, 2025, TRDA quarterly cash flow from investing activities is $53.37 million, with the most recent change of +$136.29 million (+164.35%) on December 1, 2024.
- Over the past year, TRDA quarterly CFI has stayed the same.
- TRDA quarterly CFI is now at all-time high.
Performance
TRDA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$27.80 M
+$34.32 M+55.25%
December 1, 2024
Summary
- As of March 12, 2025, TRDA TTM cash flow from investing activities is -$27.80 million, with the most recent change of +$34.32 million (+55.25%) on December 1, 2024.
- Over the past year, TRDA TTM CFI has stayed the same.
- TRDA TTM CFI is now -262.85% below its all-time high of $17.07 million, reached on June 30, 2024.
Performance
TRDA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TRDA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +79.9% | 0.0% | 0.0% |
| 3 y3 years | -506.9% | +184.0% | +81.3% |
| 5 y5 years | -4312.4% | +184.0% | +81.3% |
TRDA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -506.9% | +81.3% | at high | +129.4% | -262.9% | +85.0% |
| 5 y | 5-year | -4312.4% | +81.3% | at high | +129.4% | -262.9% | +85.0% |
| alltime | all time | -4312.4% | +81.3% | at high | +129.4% | -262.9% | +85.0% |
Entrada Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$27.80 M(-79.9%) | $53.37 M(-164.4%) | -$27.80 M(-55.3%) |
| Sep 2024 | - | -$82.93 M(+240.1%) | -$62.12 M(-463.9%) |
| Jun 2024 | - | -$24.38 M(-193.3%) | $17.07 M(-123.8%) |
| Mar 2024 | - | $26.15 M(+37.3%) | -$71.80 M(-48.1%) |
| Dec 2023 | -$138.40 M(-6.9%) | $19.04 M(-609.6%) | -$138.40 M(-0.2%) |
| Sep 2023 | - | -$3.74 M(-96.7%) | -$138.65 M(-4.4%) |
| Jun 2023 | - | -$113.26 M(+180.0%) | -$145.04 M(+1818.3%) |
| Mar 2023 | - | -$40.44 M(-315.2%) | -$7.56 M(-94.9%) |
| Dec 2022 | -$148.65 M | $18.79 M(-285.4%) | -$148.65 M(-11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$10.13 M(-141.8%) | -$168.76 M(+5.9%) |
| Jun 2022 | - | $24.23 M(-113.3%) | -$159.44 M(-13.9%) |
| Mar 2022 | - | -$181.53 M(>+9900.0%) | -$185.21 M(+3943.8%) |
| Dec 2021 | -$4.58 M(+97.6%) | -$1.32 M(+64.0%) | -$4.58 M(+40.6%) |
| Sep 2021 | - | -$806.00 K(-47.8%) | -$3.26 M(+32.9%) |
| Jun 2021 | - | -$1.54 M(+70.0%) | -$2.45 M(+170.0%) |
| Mar 2021 | - | -$908.00 K | -$908.00 K |
| Dec 2020 | -$2.32 M(+267.9%) | - | - |
| Dec 2019 | -$630.00 K | - | - |
FAQ
- What is Entrada Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Entrada Therapeutics?
- What is Entrada Therapeutics annual CFI year-on-year change?
- What is Entrada Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly CFI year-on-year change?
- What is Entrada Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Entrada Therapeutics?
- What is Entrada Therapeutics TTM CFI year-on-year change?
What is Entrada Therapeutics annual cash flow from investing activities?
The current annual CFI of TRDA is -$27.80 M
What is the all time high annual CFI for Entrada Therapeutics?
Entrada Therapeutics all-time high annual cash flow from investing activities is -$630.00 K
What is Entrada Therapeutics annual CFI year-on-year change?
Over the past year, TRDA annual cash flow from investing activities has changed by +$110.60 M (+79.91%)
What is Entrada Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TRDA is $53.37 M
What is the all time high quarterly CFI for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly cash flow from investing activities is $53.37 M
What is Entrada Therapeutics quarterly CFI year-on-year change?
Over the past year, TRDA quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Entrada Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TRDA is -$27.80 M
What is the all time high TTM CFI for Entrada Therapeutics?
Entrada Therapeutics all-time high TTM cash flow from investing activities is $17.07 M
What is Entrada Therapeutics TTM CFI year-on-year change?
Over the past year, TRDA TTM cash flow from investing activities has changed by $0.00 (0.00%)